Mednet Logo

How do you approach tapering medications in patients with CSU who are stable on both antihistamines and biologics?

Is there any evidence that guides your decision making?
Community PollStarted

What best describes your tapering approach for a patient with CSU in sustained remission on both antihistamines and biologics?

35 physicians have voted

Join Mednetto vote and see how they answered.

3 Answers
Mednet Member
Mednet Member
Allergy & Immunology · Cleveland Clinic Lerner College of Medicine at Case
Answered on

It is important to recognize that, in contrast to asthma – a lifelong condition- chronic spontaneous urticaria typically spans a period of time (e.g., 2-5 years) and then becomes evanescent. For this reason, when a patient is completely controlled, it is in a patient’s best health care interest to p...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Allergy & Immunology · Allergy Asthma And Immunology Associates Of South Texas
Answered on

Consensus is to taper the antihistamines first, and if stability is sustained, then we space out the biologic by increasing the time between injections (for example, from every four weeks to six weeks, then to eight weeks), maintaining each new frequency for a few months to ensure stability.

Detail:...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Dermatology · University of Saskatchewan
Answered on

I would consider tapering after adequate control has been sustained (e.g., 3-6 months). Before tapering, I confirm disease control and plan for a reassessment. Although there are many ways I’ve seen clinicians approach this, generally I would consider changing one medication at a time (e.g., if a pa...

Join for free or sign in to see the full answer